Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 27

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 27
---
 exercise
price of the Series A Warrants will be reduced to the lowest VWAP during such period and the number of shares issuable upon exercise
will be proportionately adjusted such that the aggregate price will remain unchanged, subject to the Series A Floor Price then in effect
(the “Share Combination Event Adjustment”).

<div align='center'>16</div>

Cashless Exercise

If, at the time a holder exercises its Series A Warrants, a registration
statement registering the issuance of the shares of Common Stock underlying the Series A Warrants under the Securities Act is
not then effective or the prospectus contained therein is not available for the issuance of such shares, then the Series A Warrant
may be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the holder shall be entitled
to receive a number of shares equal of our Common Stock in accordance with the formula set forth in the Series A Warrant.

Fundamental Transactions

In the event we consummate a merger or consolidation with or into another
person or other reorganization event in which our Common Stock is converted or exchanged for securities, cash or other property, or we
sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of our assets or we or another person
acquire more than 50% of our outstanding shares of our Common Stock, then following such event, the holders of the Series A Warrants
will be entitled to receive upon exercise of the Series A Warrants the same type and amount of securities, cash or property which
the holders would have received had they exercised the Series A Warrants immediately prior to such fundamental transaction. Any successor
to us or surviving entity shall assume the obligations under the Series A Warrants. Additionally, as more fully described in the
Series A Warrants, in the event of certain fundamental transactions, the holders of the Series A Warrants will be entitled to
receive consideration in an amount equal to the Black Scholes value of such Series A Warrants on the date of consummation of such
transaction.

Any reduction to the exercise prices of the Series A Warrants
and resulting increase in the number of shares of Common Stock underlying the Warrants will be subject to the Series A Floor Price then
in effect.

Transferability

Subject to applicable laws, a Series A Warrant
may be transferred at the option of the holder upon surrender of the Series A Warrant to us together with the appropriate instruments
of transfer